EMERGENT BIOSOLUTIONS (EBS) Covered Calls

EMERGENT BIOSOLUTIONS covered calls A biopharmaceutical company, which is focused on the development, manufacture and commercialization of vaccine and immune-related therapeutic that assist the body's immune system to prevent or treat disease.

You can sell covered calls on EMERGENT BIOSOLUTIONS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for EBS (prices last updated Tue 4:16 PM ET):

EMERGENT BIOSOLUTIONS (EBS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
57.62 +1.10 55.01 58.99 147K 22 2.8B
Covered Calls For EMERGENT BIOSOLUTIONS (EBS)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 60 0.00 58.99 0.0% 0.0%
Sep 21 60 0.25 58.74 0.4% 3.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Emergent BioSolutions, Inc. is a biopharmaceutical company. It focuses on the research, development and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction. The company operates through two segments: Biodefense and Biosciences. The Biodefense segment focuses on vaccines and antibody therapies for use against the infectious disease anthrax. The Biosciences segment focuses on protein therapies to treat certain types of cancer and vaccines for use against infectious diseases. The company was founded in May 1998 and is headquartered in Gaithersburg, MD.